top of page
Blog


Improved access to GLP-1RA medications
The White House announced today that the prescription medications, Wegovy and Zepbound, used for chronic weight management, will now be covered by Medicare-covered patients for a co-pay of $50 per month. Ozempic (indicated for Type 2 Diabetes) and Wegovy (indicated for chronic weight management) will now cost $350 per month when purchased through TrumpRx. Zepbound (indicated for chronic weight management) will now cost an average of $346 per month. Orforglipron, Eli Lilly's h
Nov 6


Did you know obesity can affect psoriasis?
Obesity can affect all organs, including the skin. Excess fat tissue in the body may lead to high levels of inflammation, which can adversely affect different organs, including the skin, and worsening autoimmune skin conditions like psoriasis. Dr. Jennifer Soung, a world-renowned dermatogist and psoriasis expert (and a dear friend and colleague) presented important information on the impact of obesity treatments on psoriasis at the International Psoriasis Council in April th
Oct 30


Malnutrition risk with GLP-1 medication use
GLP (glucagon-like peptide) medications such as Wegovy or Zepbound have revolutionized our ability to treat medical obesity and overweight and help prevent complications with other major organs such as the heart, liver, kidney, and even skin. But needs to be discussed more openly is the risk of malnutrition. Imagine if you had to cut your caloric intake in half (or even more) and had to get in all the same nutrition (and fluids!) into your body. Then imagine if you lost yo
Oct 27

NEWSLETTER
If my story and purpose resonates, I invite you to sign up for my newsletter. You'll occasionally receive important medical information and updates on my medical journey and advocacy work.
bottom of page
